MARATTO

article · Records of Pharmaceutical and Biomedical Sciences/Records of Pharmaceutical & Biomedical Sciences

Review Article on Phytochemical Constituents and Biological Activity of Cleome amblyocarpa.

2024Open accessSuez Canal University

Abstract

Cleome amblyocarpa (Barratte & Murb.) is widely growing in desert sandy habitats of Sinai, Egypt, and many parts of North Africa. Along the history, C. amblyocarpa, family Cleomaceae is frequently used to treat a variety of illnesses in traditional medicine. The plant was selected based on the outstanding results of a previous biological study that Correspondence Author conducted on a plant extract of C. amblyocarpa. : Use as anticancer, anti-inflammatory, gastrointestinal disorders, anti-diabetic, antimicrobial and anthelmintic. Several species of Cleomaceae have been reported to contain numerous phytochemicals such as triterpenoids, sterols, flavonoids, saponins, alkaloids, polyacetylenes and coumarins. The phytochemical components of this significant and useful genus are highlighted in this review, along with its several documented biological functions. In order to maximize the medicinal and nutritional benefits of C. amblyocarpa, more research on the active ingredients in this plant is necessary. This is because the plant extract is unquestionably a good source of components that strengthen health and may be utilized for both nutritional and therapeutic purposes.

Research topics

  • Phytochemistry and Biological Activities
  • Ethnobotanical and Medicinal Plants Studies
  • Pharmacological Effects of Natural Compounds

Sustainable Development Goals

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

DOI: 10.21608/rpbs.2024.281837.1289

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.